HCP, Inc. (NYSE:HCP) COO Thomas Klaritch sold 82,532 shares of the business’s stock in a transaction that occurred on Tuesday, December 4th. The stock was sold at an average price of $29.51, for a total transaction of $2,435,519.32. Following the sale, the chief operating officer now owns 256,280 shares of the company’s stock, valued at approximately $7,562,822.80. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Shares of NYSE:HCP traded up $1.15 on Thursday, reaching $30.23. 7,406,607 shares of the company were exchanged, compared to its average volume of 3,562,895. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 1.21. HCP, Inc. has a 1-year low of $21.48 and a 1-year high of $30.26. The stock has a market cap of $13.67 billion, a PE ratio of 15.50, a price-to-earnings-growth ratio of 7.33 and a beta of 0.23.
HCP (NYSE:HCP) last posted its quarterly earnings results on Wednesday, October 31st. The real estate investment trust reported $0.21 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.11 by $0.10. HCP had a net margin of 9.16% and a return on equity of 3.06%. The business had revenue of $456.00 million for the quarter, compared to analysts’ expectations of $456.59 million. During the same period in the prior year, the company posted $0.48 EPS. The business’s revenue for the quarter was up .4% on a year-over-year basis. Equities analysts anticipate that HCP, Inc. will post 1.82 earnings per share for the current year.
Several research firms recently commented on HCP. Robert W. Baird upped their price target on shares of HCP from $24.00 to $26.00 and gave the company a “neutral” rating in a research report on Thursday, August 9th. Zacks Investment Research reiterated a “sell” rating on shares of HCP in a research report on Tuesday, November 13th. Morgan Stanley upped their price target on shares of HCP from $23.50 to $25.00 and gave the company an “equal weight” rating in a research report on Thursday, August 16th. Mizuho reissued a “buy” rating and issued a $29.00 price objective on shares of HCP in a research note on Monday, August 13th. Finally, Cantor Fitzgerald boosted their price objective on shares of HCP from $29.00 to $30.00 and gave the company an “overweight” rating in a research note on Thursday, November 1st. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $26.75.
Several large investors have recently bought and sold shares of HCP. Carnegie Capital Asset Management LLC grew its stake in HCP by 29.7% in the 3rd quarter. Carnegie Capital Asset Management LLC now owns 10,925 shares of the real estate investment trust’s stock valued at $317,000 after acquiring an additional 2,500 shares during the last quarter. Vanguard Group Inc. grew its stake in HCP by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 75,247,949 shares of the real estate investment trust’s stock valued at $1,980,527,000 after acquiring an additional 196,049 shares during the last quarter. Legal & General Group Plc grew its stake in HCP by 1.2% in the 3rd quarter. Legal & General Group Plc now owns 3,690,653 shares of the real estate investment trust’s stock valued at $97,108,000 after acquiring an additional 44,998 shares during the last quarter. Standard Life Aberdeen plc grew its stake in HCP by 3.3% in the 3rd quarter. Standard Life Aberdeen plc now owns 249,259 shares of the real estate investment trust’s stock valued at $6,562,000 after acquiring an additional 7,990 shares during the last quarter. Finally, Rehmann Capital Advisory Group grew its stake in HCP by 2,572.2% in the 3rd quarter. Rehmann Capital Advisory Group now owns 26,188 shares of the real estate investment trust’s stock valued at $995,000 after acquiring an additional 25,208 shares during the last quarter. 90.00% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: This news story was first reported by WKRB News and is the property of of WKRB News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.wkrb13.com/2018/12/07/hcp-inc-hcp-coo-thomas-klaritch-sells-82532-shares.html.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.